Publications en collaboration avec des chercheurs de Universidad de Salamanca (32)

2019

  1. Maturation-associated gene expression profiles during normal human bone marrow erythropoiesis

    Cell Death Discovery, Vol. 5, Núm. 1

2017

  1. Maturation-associated gene expression profiles along normal human bone marrow monopoiesis

    British Journal of Haematology, Vol. 176, Núm. 3, pp. 464-474

2016

  1. Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: A new model to understand chemoresistance

    Blood, Vol. 127, Núm. 15, pp. 1896-1906

  2. Phenotypic, transcriptomic, and genomic features of clonal plasma cells in light-chain amyloidosis

    Blood, Vol. 127, Núm. 24, pp. 3035-3039

2015

  1. Ex vivo identification and characterization of a population of CD13high CD105+ CD45- mesenchymal stem cells in human bone marrow

    Stem Cell Research and Therapy, Vol. 6, Núm. 1

  2. Phenotypic identification of subclones in multiple myeloma with different chemoresistant, cytogenetic and clonogenic potential

    Leukemia, Vol. 29, Núm. 5, pp. 1186-1194

  3. Phenotypic profile of expanded NK cells in chronic lymphoproliferative disorders: A surrogate marker for NK-cell clonality

    Oncotarget, Vol. 6, Núm. 40, pp. 42938-42951

  4. The cellular origin and malignant transformation of Waldenström macroglobulinemia

    Blood, Vol. 125, Núm. 15, pp. 2370-2380

2014

  1. Immunophenotypic alterations of bone marrow myeloid cell compartments in multiple myeloma patients predict for myelodysplasia-associated cytogenetic alterations

    Leukemia

  2. Involvement of primary mesenchymal precursors and hematopoietic bone marrow cells from chronic myeloid leukemia patients by BCR-ABL1 fusion gene

    American Journal of Hematology, Vol. 89, Núm. 3, pp. 288-294

2013

  1. Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile

    Blood, Vol. 122, Núm. 22, pp. 3591-3598

  2. Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosis

    Journal of Allergy and Clinical Immunology, Vol. 131, Núm. 4

2011

  1. Evaluation of the WHO criteria for the classification of patients with mastocytosis

    Modern Pathology, Vol. 24, Núm. 9, pp. 1157-1168

2010

  1. Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: A pilot study on A series of 56 patients

    Cytometry Part B - Clinical Cytometry, Vol. 78, Núm. 3, pp. 154-168

2009

  1. Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach

    Blood, Vol. 114, Núm. 1, pp. 33-37

2008

  1. Association between the proliferative rate of neoplastic B cells, their maturation stage, and underlying cytogenetic abnormalities in B-cell chronic lymphoproliferative disorders: Analysis of a series of 432 patients

    Blood, Vol. 111, Núm. 10, pp. 5130-5141

  2. Detailed immunophenotypic characterization of different major and minor subsets of peripheral blood cells in patients with paroxysmal nocturnal hemoglobinuria

    Transfusion, Vol. 48, Núm. 7, pp. 1403-1414

  3. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia

    Cytometry Part B - Clinical Cytometry, Vol. 74, Núm. 3, pp. 139-149

  4. The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors

    Leukemia, Vol. 22, Núm. 6, pp. 1175-1183

2007

  1. Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: Comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals

    Leukemia, Vol. 21, Núm. 3, pp. 541-549